Halting antiviral therapy in patients with cirrhosis and chronic hepatitis B: A dangerous game?

被引：0
|
作者：
Chen, Jacki [1 ,2 ]
Tu, Thomas [3 ]
Cohen, Chari [4 ]
Wang, Su [4 ,5 ]
Hsu, Yao-Chun [6 ,7 ]
Gish, Robert G. [4 ,8 ,9 ,10 ]
机构：
[1] Taiwan Hepatitis Informat & Care Assoc, Kaohsiung, Taiwan
[2] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Pharmacol, Piscataway, NJ USA
[3] Univ Sydney, Westmead Inst Med Res, Storr Liver Ctr, Westmead Hosp, Westmead, NSW, Australia
[4] Hepatitis B Fdn, Doylestown, PA USA
[5] RWJBarnabas Rutgers Med Grp, Ctr Asian Hlth, Cooperman Barnabas Med Ctr, Livingston, NJ USA
[6] E Da Hosp, Div Gastroenterol & Hepatol, Kaohsiung, Taiwan
[7] I Shou Univ, Coll Med, Sch Med, Kaohsiung, Taiwan
[8] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA USA
[9] Univ Nevada, Reno Sch Med, Reno, NV USA
[10] Robert G Gish Consultants LLC, 6022 La Jolla Mesa Dr, La Jolla, CA 92037 USA
来源：
HEPATOLOGY | 2024年 / 79卷 / 05期
关键词：
D O I：
10.1097/HEP.0000000000000732
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E132 / E133
页数：2
相关论文
共 50 条
  • [31] Molecular mechanisms of resistance to antiviral therapy in patients with chronic hepatitis B
    Yuan, He-Jun
    Lee, William M.
    CURRENT MOLECULAR MEDICINE, 2007, 7 (02) : 185 - 197
  • [32] Tailoring antiviral therapy in chronic hepatitis B patients with lamivudine resistance
    Brunetto, Maurizia Rossana
    JOURNAL OF HEPATOLOGY, 2007, 46 (05) : 756 - 758
  • [33] REDUCTION OF LIVER STIFFNESS OF CHRONIC HEPATITIS B PATIENTS BY ANTIVIRAL THERAPY
    Yoshioka, Kentaro
    Harata, Masao
    Osakabe, Keisuke
    Hashimoto, Senju
    Kawabe, Naoto
    Nitta, Yoshifumi
    Murao, Michihito
    Nakano, Takuji
    Arima, Yuko
    Shimazaki, Hiroaki
    Ichino, Naohiro
    Nishikawa, Toru
    HEPATOLOGY, 2010, 52 (04) : 502A - 502A
  • [34] Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy
    John Vlachogiannakos
    George Papatheodoridis
    World Journal of Gastroenterology, 2013, (47) : 8822 - 8830
  • [35] Antiviral Therapy in Decompensated Cirrhosis due to Hepatitis B Virus
    Fu, Qingchun
    Chen, Chengwei
    GUT AND LIVER, 2011, 174 : 123 - 126
  • [36] Successful antiviral therapy and prognosis in cirrhosis due to hepatitis B
    Han, SHB
    Martin, P
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (06): : 859 - 860
  • [37] Reversal of cirrhosis: An achievable goal of hepatitis B antiviral therapy
    Liaw, Yun-Fan
    JOURNAL OF HEPATOLOGY, 2013, 59 (04) : 880 - 881
  • [38] Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
    Ju, Young-Cheol
    Jun, Dae-Won
    Choi, Jun
    Saeed, Waciar Khalid
    Lee, Hyo-Young
    Oh, Hyun-Woo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (40) : 4606 - 4614
  • [39] Long term outcome of antiviral therapy in patients with hepatitis B associated decompensated cirrhosis
    Young-Cheol Ju
    Dae-Won Jun
    Jun Choi
    Waqar Khalid Saeed
    Hyo-Young Lee
    Hyun-Woo Oh
    World Journal of Gastroenterology, 2018, (40) : 4606 - 4614
  • [40] Lower liver cancer risk with antiviral therapy in chronic hepatitis B patients with normal to minimally elevated ALT and no cirrhosis
    Hoang, Joseph K.
    Yang, Hwai-I
    Le, An
    Nguyen, Nghia H.
    Lin, Derek
    Vu, Vinh D.
    Chaung, Kevin
    Nguyen, Vincent
    Trinh, Huy N.
    Li, Jiayi
    Zhang, Jian Q.
    Chen, Chien-Jen
    Nguyen, Mindie H.
    MEDICINE, 2016, 95 (31)
12345